INS and Alzheimer disease: Moreover, in accordance with the results obtained with anti-diabetic drugs in animal models of Alzheimer’s disease (AD), IN insulin showed the ability to modulate the plasma levels of amyloid β (Aβ) [110], thereby improving delayed memory and preserving cognitive function in patients with amnestic mild cognitive impairment and AD [111].